Flucloxacillin + ampicillin
Co-fluampicil
Brand names: Magnapen
Adult dose
Dose: 1 cap (250mg/250mg) QDS, doubled in severe infection
Route: PO/IV
Frequency: QDS
Clinical pearls
- Combined gram-positive (S. aureus) + broader cover; use largely superseded
- Co-amoxiclav generally preferred
Contraindications
- Penicillin hypersensitivity
- Cholestatic jaundice with flucloxacillin
Side effects
- GI upset
- Rash
- Cholestatic hepatitis (esp. flucloxacillin)
- C. difficile
Interactions
- Methotrexate (toxicity)
- Warfarin (variable)
Reference: BNF; https://bnf.nice.org.uk/drugs/co-fluampicil/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Infective Endocarditis · ESC 2023 Infective Endocarditis Guidelines; NICE NG41
- Eczema Herpeticum · BAD; NICE CKS
- Suspected Bacterial Meningitis (Adult) · NICE NG240 (2024); NICE NG143 (paeds)
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021
- Returning Traveller — Fever · NaTHNaC; PHE; ESCMID 2018
- Malaria — Diagnosis & Management · PHE 2016; WHO 2023